Suggestions

Du même auteur

Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor

Archive ouverte | Niu, Huifeng | CCSD

International audience. BACKGROUND:Alisertib (MLN8237) is an investigational, oral, selective Aurora A kinase inhibitor. Aurora A contains two functional single nucleotide polymorphisms (SNPs; codon 31 [F/I] and cod...

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Archive ouverte | Garassino, Marina, Chiara | CCSD

International audience. has a patent T-cell immunotherapy development pending; is a founder and owner of BioCytics, which is a clinical research laboratory developing T-cell immunotherapy; and has previously bought ...

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Archive ouverte | Antonia, Scott | CCSD

International audience. BACKGROUND:An earlier analysis in this phase 3 trial showed that durvalumab significantly prolonged progression-free survival, as compared with placebo, among patients with stage III, unresec...

Chargement des enrichissements...